0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical IVD Reagents Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-22Z18619
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Clinical IVD Reagents Market Research Report 2024
BUY CHAPTERS

Global Clinical IVD Reagents Market Research Report 2026

Code: QYRE-Auto-22Z18619
Report
2026-01-19
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical IVD Reagents Market Size

The global Clinical IVD Reagents market was valued at US$ 1573 million in 2025 and is anticipated to reach US$ 2175 million by 2032, at a CAGR of 4.8% from 2026 to 2032.

Clinical IVD Reagents Market

Clinical IVD Reagents Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Clinical IVD Reagents competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Clinical In Vitro Diagnostic (IVD) Reagents are substances or compounds used in laboratory tests to detect, monitor, or diagnose diseases or medical conditions in biological samples (such as blood, urine, saliva, or tissues). These reagents are part of in vitro diagnostic (IVD) tests, which are performed outside the body (in vitro), typically in a clinical or laboratory setting, to analyze samples and provide valuable health information.
The North American market for Clinical IVD Reagents is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Clinical IVD Reagents is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Clinical IVD Reagents include Danaher, Roche, Abbott, Siemen, Thermo Fisher Scientific, Illumina, BioMerieux, BD, Hologic, Bio-Rad, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Clinical IVD Reagents market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Clinical IVD Reagents. The Clinical IVD Reagents market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Clinical IVD Reagents market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Clinical IVD Reagents manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Clinical IVD Reagents Market Report

Report Metric Details
Report Name Clinical IVD Reagents Market
Accounted market size in 2025 US$ 1573 million
Forecasted market size in 2032 US$ 2175 million
CAGR 4.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Antibodies
  • Antigens, Purified Proteins and Peptides
  • Olignucleotides
  • Others
by Application
  • Infectious Diseases
  • Oncology Applications
  • Endocrinology
  • Blood Sreening
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Danaher, Roche, Abbott, Siemen, Thermo Fisher Scientific, Illumina, BioMerieux, BD, Hologic, Bio-Rad, Sysmex, QIAGEN, Agilent, Revvity, DiaSorin, Grifols, Werfen, QuidelOrtho, Chembio Diagnostics, Surmodics, Merck KGaA, MBL Life Science, Canvax, Prestige Diagnostics, Adaltis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Clinical IVD Reagents manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Clinical IVD Reagents sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Clinical IVD Reagents Market growing?

Ans: The Clinical IVD Reagents Market witnessing a CAGR of 4.8% during the forecast period 2026-2032.

What is the Clinical IVD Reagents Market size in 2032?

Ans: The Clinical IVD Reagents Market size in 2032 will be US$ 2175 million.

Who are the main players in the Clinical IVD Reagents Market report?

Ans: The main players in the Clinical IVD Reagents Market are Danaher, Roche, Abbott, Siemen, Thermo Fisher Scientific, Illumina, BioMerieux, BD, Hologic, Bio-Rad, Sysmex, QIAGEN, Agilent, Revvity, DiaSorin, Grifols, Werfen, QuidelOrtho, Chembio Diagnostics, Surmodics, Merck KGaA, MBL Life Science, Canvax, Prestige Diagnostics, Adaltis

What are the Application segmentation covered in the Clinical IVD Reagents Market report?

Ans: The Applications covered in the Clinical IVD Reagents Market report are Infectious Diseases, Oncology Applications, Endocrinology, Blood Sreening, Others

What are the Type segmentation covered in the Clinical IVD Reagents Market report?

Ans: The Types covered in the Clinical IVD Reagents Market report are Antibodies, Antigens, Purified Proteins and Peptides, Olignucleotides, Others

1 Clinical IVD Reagents Market Overview
1.1 Product Definition
1.2 Clinical IVD Reagents by Type
1.2.1 Global Clinical IVD Reagents Market Value by Type: 2025 vs 2032
1.2.2 Antibodies
1.2.3 Antigens, Purified Proteins and Peptides
1.2.4 Olignucleotides
1.2.5 Others
1.3 Clinical IVD Reagents by Application
1.3.1 Global Clinical IVD Reagents Market Value by Application: 2025 vs 2032
1.3.2 Infectious Diseases
1.3.3 Oncology Applications
1.3.4 Endocrinology
1.3.5 Blood Sreening
1.3.6 Others
1.4 Global Clinical IVD Reagents Market Size Estimates and Forecasts
1.4.1 Global Clinical IVD Reagents Revenue 2021–2032
1.4.2 Global Clinical IVD Reagents Sales 2021–2032
1.4.3 Global Clinical IVD Reagents Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Clinical IVD Reagents Market Competition by Manufacturers
2.1 Global Clinical IVD Reagents Sales Market Share by Manufacturers (2021–2026)
2.2 Global Clinical IVD Reagents Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Clinical IVD Reagents Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Clinical IVD Reagents, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Clinical IVD Reagents, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Clinical IVD Reagents, Product Types and Applications
2.7 Global Key Manufacturers of Clinical IVD Reagents, Date of Entry into the Industry
2.8 Global Clinical IVD Reagents Market Competitive Situation and Trends
2.8.1 Global Clinical IVD Reagents Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Clinical IVD Reagents Players Market Share by Revenue
2.8.3 Global Clinical IVD Reagents Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Clinical IVD Reagents Market Scenario by Region
3.1 Global Clinical IVD Reagents Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Clinical IVD Reagents Sales by Region: 2021–2032
3.2.1 Global Clinical IVD Reagents Sales by Region: 2021–2026
3.2.2 Global Clinical IVD Reagents Sales by Region: 2027–2032
3.3 Global Clinical IVD Reagents Revenue by Region: 2021–2032
3.3.1 Global Clinical IVD Reagents Revenue by Region: 2021–2026
3.3.2 Global Clinical IVD Reagents Revenue by Region: 2027–2032
3.4 North America Clinical IVD Reagents Market Facts & Figures by Country
3.4.1 North America Clinical IVD Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Clinical IVD Reagents Sales by Country (2021–2032)
3.4.3 North America Clinical IVD Reagents Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Clinical IVD Reagents Market Facts & Figures by Country
3.5.1 Europe Clinical IVD Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Clinical IVD Reagents Sales by Country (2021–2032)
3.5.3 Europe Clinical IVD Reagents Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Clinical IVD Reagents Market Facts & Figures by Region
3.6.1 Asia Pacific Clinical IVD Reagents Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Clinical IVD Reagents Sales by Region (2021–2032)
3.6.3 Asia Pacific Clinical IVD Reagents Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Clinical IVD Reagents Market Facts & Figures by Country
3.7.1 Latin America Clinical IVD Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Clinical IVD Reagents Sales by Country (2021–2032)
3.7.3 Latin America Clinical IVD Reagents Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Clinical IVD Reagents Market Facts & Figures by Country
3.8.1 Middle East and Africa Clinical IVD Reagents Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Clinical IVD Reagents Sales by Country (2021–2032)
3.8.3 Middle East and Africa Clinical IVD Reagents Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Clinical IVD Reagents Sales by Type (2021–2032)
4.1.1 Global Clinical IVD Reagents Sales by Type (2021–2026)
4.1.2 Global Clinical IVD Reagents Sales by Type (2027–2032)
4.1.3 Global Clinical IVD Reagents Sales Market Share by Type (2021–2032)
4.2 Global Clinical IVD Reagents Revenue by Type (2021–2032)
4.2.1 Global Clinical IVD Reagents Revenue by Type (2021–2026)
4.2.2 Global Clinical IVD Reagents Revenue by Type (2027–2032)
4.2.3 Global Clinical IVD Reagents Revenue Market Share by Type (2021–2032)
4.3 Global Clinical IVD Reagents Price by Type (2021–2032)
5 Segment by Application
5.1 Global Clinical IVD Reagents Sales by Application (2021–2032)
5.1.1 Global Clinical IVD Reagents Sales by Application (2021–2026)
5.1.2 Global Clinical IVD Reagents Sales by Application (2027–2032)
5.1.3 Global Clinical IVD Reagents Sales Market Share by Application (2021–2032)
5.2 Global Clinical IVD Reagents Revenue by Application (2021–2032)
5.2.1 Global Clinical IVD Reagents Revenue by Application (2021–2026)
5.2.2 Global Clinical IVD Reagents Revenue by Application (2027–2032)
5.2.3 Global Clinical IVD Reagents Revenue Market Share by Application (2021–2032)
5.3 Global Clinical IVD Reagents Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Danaher
6.1.1 Danaher Company Information
6.1.2 Danaher Description and Business Overview
6.1.3 Danaher Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Danaher Clinical IVD Reagents Product Portfolio
6.1.5 Danaher Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Roche Clinical IVD Reagents Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbott Clinical IVD Reagents Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Siemen
6.4.1 Siemen Company Information
6.4.2 Siemen Description and Business Overview
6.4.3 Siemen Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Siemen Clinical IVD Reagents Product Portfolio
6.4.5 Siemen Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Thermo Fisher Scientific Clinical IVD Reagents Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Illumina
6.6.1 Illumina Company Information
6.6.2 Illumina Description and Business Overview
6.6.3 Illumina Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Illumina Clinical IVD Reagents Product Portfolio
6.6.5 Illumina Recent Developments/Updates
6.7 BioMerieux
6.7.1 BioMerieux Company Information
6.7.2 BioMerieux Description and Business Overview
6.7.3 BioMerieux Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 BioMerieux Clinical IVD Reagents Product Portfolio
6.7.5 BioMerieux Recent Developments/Updates
6.8 BD
6.8.1 BD Company Information
6.8.2 BD Description and Business Overview
6.8.3 BD Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BD Clinical IVD Reagents Product Portfolio
6.8.5 BD Recent Developments/Updates
6.9 Hologic
6.9.1 Hologic Company Information
6.9.2 Hologic Description and Business Overview
6.9.3 Hologic Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hologic Clinical IVD Reagents Product Portfolio
6.9.5 Hologic Recent Developments/Updates
6.10 Bio-Rad
6.10.1 Bio-Rad Company Information
6.10.2 Bio-Rad Description and Business Overview
6.10.3 Bio-Rad Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bio-Rad Clinical IVD Reagents Product Portfolio
6.10.5 Bio-Rad Recent Developments/Updates
6.11 Sysmex
6.11.1 Sysmex Company Information
6.11.2 Sysmex Description and Business Overview
6.11.3 Sysmex Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sysmex Clinical IVD Reagents Product Portfolio
6.11.5 Sysmex Recent Developments/Updates
6.12 QIAGEN
6.12.1 QIAGEN Company Information
6.12.2 QIAGEN Description and Business Overview
6.12.3 QIAGEN Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 QIAGEN Clinical IVD Reagents Product Portfolio
6.12.5 QIAGEN Recent Developments/Updates
6.13 Agilent
6.13.1 Agilent Company Information
6.13.2 Agilent Description and Business Overview
6.13.3 Agilent Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Agilent Clinical IVD Reagents Product Portfolio
6.13.5 Agilent Recent Developments/Updates
6.14 Revvity
6.14.1 Revvity Company Information
6.14.2 Revvity Description and Business Overview
6.14.3 Revvity Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Revvity Clinical IVD Reagents Product Portfolio
6.14.5 Revvity Recent Developments/Updates
6.15 DiaSorin
6.15.1 DiaSorin Company Information
6.15.2 DiaSorin Description and Business Overview
6.15.3 DiaSorin Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 DiaSorin Clinical IVD Reagents Product Portfolio
6.15.5 DiaSorin Recent Developments/Updates
6.16 Grifols
6.16.1 Grifols Company Information
6.16.2 Grifols Description and Business Overview
6.16.3 Grifols Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Grifols Clinical IVD Reagents Product Portfolio
6.16.5 Grifols Recent Developments/Updates
6.17 Werfen
6.17.1 Werfen Company Information
6.17.2 Werfen Description and Business Overview
6.17.3 Werfen Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Werfen Clinical IVD Reagents Product Portfolio
6.17.5 Werfen Recent Developments/Updates
6.18 QuidelOrtho
6.18.1 QuidelOrtho Company Information
6.18.2 QuidelOrtho Description and Business Overview
6.18.3 QuidelOrtho Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 QuidelOrtho Clinical IVD Reagents Product Portfolio
6.18.5 QuidelOrtho Recent Developments/Updates
6.19 Chembio Diagnostics
6.19.1 Chembio Diagnostics Company Information
6.19.2 Chembio Diagnostics Description and Business Overview
6.19.3 Chembio Diagnostics Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Chembio Diagnostics Clinical IVD Reagents Product Portfolio
6.19.5 Chembio Diagnostics Recent Developments/Updates
6.20 Surmodics
6.20.1 Surmodics Company Information
6.20.2 Surmodics Description and Business Overview
6.20.3 Surmodics Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Surmodics Clinical IVD Reagents Product Portfolio
6.20.5 Surmodics Recent Developments/Updates
6.21 Merck KGaA
6.21.1 Merck KGaA Company Information
6.21.2 Merck KGaA Description and Business Overview
6.21.3 Merck KGaA Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Merck KGaA Clinical IVD Reagents Product Portfolio
6.21.5 Merck KGaA Recent Developments/Updates
6.22 MBL Life Science
6.22.1 MBL Life Science Company Information
6.22.2 MBL Life Science Description and Business Overview
6.22.3 MBL Life Science Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 MBL Life Science Clinical IVD Reagents Product Portfolio
6.22.5 MBL Life Science Recent Developments/Updates
6.23 Canvax
6.23.1 Canvax Company Information
6.23.2 Canvax Description and Business Overview
6.23.3 Canvax Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Canvax Clinical IVD Reagents Product Portfolio
6.23.5 Canvax Recent Developments/Updates
6.24 Prestige Diagnostics
6.24.1 Prestige Diagnostics Company Information
6.24.2 Prestige Diagnostics Description and Business Overview
6.24.3 Prestige Diagnostics Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Prestige Diagnostics Clinical IVD Reagents Product Portfolio
6.24.5 Prestige Diagnostics Recent Developments/Updates
6.25 Adaltis
6.25.1 Adaltis Company Information
6.25.2 Adaltis Description and Business Overview
6.25.3 Adaltis Clinical IVD Reagents Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Adaltis Clinical IVD Reagents Product Portfolio
6.25.5 Adaltis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Clinical IVD Reagents Industry Chain Analysis
7.2 Clinical IVD Reagents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Clinical IVD Reagents Production Mode & Process Analysis
7.4 Clinical IVD Reagents Sales and Marketing
7.4.1 Clinical IVD Reagents Sales Channels
7.4.2 Clinical IVD Reagents Distributors
7.5 Clinical IVD Reagents Customer Analysis
8 Clinical IVD Reagents Market Dynamics
8.1 Clinical IVD Reagents Industry Trends
8.2 Clinical IVD Reagents Market Drivers
8.3 Clinical IVD Reagents Market Challenges
8.4 Clinical IVD Reagents Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Clinical IVD Reagents Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Clinical IVD Reagents Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Clinical IVD Reagents Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Clinical IVD Reagents Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Clinical IVD Reagents Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Clinical IVD Reagents Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Clinical IVD Reagents Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Clinical IVD Reagents Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Clinical IVD Reagents, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Clinical IVD Reagents, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Clinical IVD Reagents, Product Types and Applications
 Table 12. Global Key Manufacturers of Clinical IVD Reagents, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Clinical IVD Reagents Companies by Tier (Tier 1, Tier 2, Tier 3), based on Clinical IVD Reagents Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Clinical IVD Reagents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Clinical IVD Reagents Sales by Region (Units), 2021–2026
 Table 18. Global Clinical IVD Reagents Sales Market Share by Region (2021–2026)
 Table 19. Global Clinical IVD Reagents Sales by Region (Units), 2027–2032
 Table 20. Global Clinical IVD Reagents Sales Market Share by Region (2027–2032)
 Table 21. Global Clinical IVD Reagents Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Clinical IVD Reagents Revenue Market Share by Region (2021–2026)
 Table 23. Global Clinical IVD Reagents Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Clinical IVD Reagents Revenue Market Share by Region (2027–2032)
 Table 25. North America Clinical IVD Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Clinical IVD Reagents Sales by Country (Units), 2021–2026
 Table 27. North America Clinical IVD Reagents Sales by Country (Units), 2027–2032
 Table 28. North America Clinical IVD Reagents Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Clinical IVD Reagents Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Clinical IVD Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Clinical IVD Reagents Sales by Country (Units), 2021–2026
 Table 32. Europe Clinical IVD Reagents Sales by Country (Units), 2027–2032
 Table 33. Europe Clinical IVD Reagents Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Clinical IVD Reagents Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Clinical IVD Reagents Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Clinical IVD Reagents Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Clinical IVD Reagents Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Clinical IVD Reagents Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Clinical IVD Reagents Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Clinical IVD Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Clinical IVD Reagents Sales by Country (Units), 2021–2026
 Table 42. Latin America Clinical IVD Reagents Sales by Country (Units), 2027–2032
 Table 43. Latin America Clinical IVD Reagents Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Clinical IVD Reagents Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Clinical IVD Reagents Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Clinical IVD Reagents Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Clinical IVD Reagents Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Clinical IVD Reagents Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Clinical IVD Reagents Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Clinical IVD Reagents Sales (Units) by Type (2021–2026)
 Table 51. Global Clinical IVD Reagents Sales (Units) by Type (2027–2032)
 Table 52. Global Clinical IVD Reagents Sales Market Share by Type (2021–2026)
 Table 53. Global Clinical IVD Reagents Sales Market Share by Type (2027–2032)
 Table 54. Global Clinical IVD Reagents Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Clinical IVD Reagents Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Clinical IVD Reagents Revenue Market Share by Type (2021–2026)
 Table 57. Global Clinical IVD Reagents Revenue Market Share by Type (2027–2032)
 Table 58. Global Clinical IVD Reagents Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Clinical IVD Reagents Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Clinical IVD Reagents Sales (Units) by Application (2021–2026)
 Table 61. Global Clinical IVD Reagents Sales (Units) by Application (2027–2032)
 Table 62. Global Clinical IVD Reagents Sales Market Share by Application (2021–2026)
 Table 63. Global Clinical IVD Reagents Sales Market Share by Application (2027–2032)
 Table 64. Global Clinical IVD Reagents Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Clinical IVD Reagents Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Clinical IVD Reagents Revenue Market Share by Application (2021–2026)
 Table 67. Global Clinical IVD Reagents Revenue Market Share by Application (2027–2032)
 Table 68. Global Clinical IVD Reagents Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Clinical IVD Reagents Price (US$/Unit) by Application (2027–2032)
 Table 70. Danaher Company Information
 Table 71. Danaher Description and Business Overview
 Table 72. Danaher Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Danaher Clinical IVD Reagents Product
 Table 74. Danaher Recent Developments/Updates
 Table 75. Roche Company Information
 Table 76. Roche Description and Business Overview
 Table 77. Roche Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Roche Clinical IVD Reagents Product
 Table 79. Roche Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Abbott Clinical IVD Reagents Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. Siemen Company Information
 Table 86. Siemen Description and Business Overview
 Table 87. Siemen Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Siemen Clinical IVD Reagents Product
 Table 89. Siemen Recent Developments/Updates
 Table 90. Thermo Fisher Scientific Company Information
 Table 91. Thermo Fisher Scientific Description and Business Overview
 Table 92. Thermo Fisher Scientific Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Thermo Fisher Scientific Clinical IVD Reagents Product
 Table 94. Thermo Fisher Scientific Recent Developments/Updates
 Table 95. Illumina Company Information
 Table 96. Illumina Description and Business Overview
 Table 97. Illumina Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Illumina Clinical IVD Reagents Product
 Table 99. Illumina Recent Developments/Updates
 Table 100. BioMerieux Company Information
 Table 101. BioMerieux Description and Business Overview
 Table 102. BioMerieux Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. BioMerieux Clinical IVD Reagents Product
 Table 104. BioMerieux Recent Developments/Updates
 Table 105. BD Company Information
 Table 106. BD Description and Business Overview
 Table 107. BD Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. BD Clinical IVD Reagents Product
 Table 109. BD Recent Developments/Updates
 Table 110. Hologic Company Information
 Table 111. Hologic Description and Business Overview
 Table 112. Hologic Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Hologic Clinical IVD Reagents Product
 Table 114. Hologic Recent Developments/Updates
 Table 115. Bio-Rad Company Information
 Table 116. Bio-Rad Description and Business Overview
 Table 117. Bio-Rad Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Bio-Rad Clinical IVD Reagents Product
 Table 119. Bio-Rad Recent Developments/Updates
 Table 120. Sysmex Company Information
 Table 121. Sysmex Description and Business Overview
 Table 122. Sysmex Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Sysmex Clinical IVD Reagents Product
 Table 124. Sysmex Recent Developments/Updates
 Table 125. QIAGEN Company Information
 Table 126. QIAGEN Description and Business Overview
 Table 127. QIAGEN Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. QIAGEN Clinical IVD Reagents Product
 Table 129. QIAGEN Recent Developments/Updates
 Table 130. Agilent Company Information
 Table 131. Agilent Description and Business Overview
 Table 132. Agilent Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Agilent Clinical IVD Reagents Product
 Table 134. Agilent Recent Developments/Updates
 Table 135. Revvity Company Information
 Table 136. Revvity Description and Business Overview
 Table 137. Revvity Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Revvity Clinical IVD Reagents Product
 Table 139. Revvity Recent Developments/Updates
 Table 140. DiaSorin Company Information
 Table 141. DiaSorin Description and Business Overview
 Table 142. DiaSorin Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. DiaSorin Clinical IVD Reagents Product
 Table 144. DiaSorin Recent Developments/Updates
 Table 145. Grifols Company Information
 Table 146. Grifols Description and Business Overview
 Table 147. Grifols Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Grifols Clinical IVD Reagents Product
 Table 149. Grifols Recent Developments/Updates
 Table 150. Werfen Company Information
 Table 151. Werfen Description and Business Overview
 Table 152. Werfen Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Werfen Clinical IVD Reagents Product
 Table 154. Werfen Recent Developments/Updates
 Table 155. QuidelOrtho Company Information
 Table 156. QuidelOrtho Description and Business Overview
 Table 157. QuidelOrtho Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. QuidelOrtho Clinical IVD Reagents Product
 Table 159. QuidelOrtho Recent Developments/Updates
 Table 160. Chembio Diagnostics Company Information
 Table 161. Chembio Diagnostics Description and Business Overview
 Table 162. Chembio Diagnostics Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Chembio Diagnostics Clinical IVD Reagents Product
 Table 164. Chembio Diagnostics Recent Developments/Updates
 Table 165. Surmodics Company Information
 Table 166. Surmodics Description and Business Overview
 Table 167. Surmodics Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Surmodics Clinical IVD Reagents Product
 Table 169. Surmodics Recent Developments/Updates
 Table 170. Merck KGaA Company Information
 Table 171. Merck KGaA Description and Business Overview
 Table 172. Merck KGaA Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 173. Merck KGaA Clinical IVD Reagents Product
 Table 174. Merck KGaA Recent Developments/Updates
 Table 175. MBL Life Science Company Information
 Table 176. MBL Life Science Description and Business Overview
 Table 177. MBL Life Science Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 178. MBL Life Science Clinical IVD Reagents Product
 Table 179. MBL Life Science Recent Developments/Updates
 Table 180. Canvax Company Information
 Table 181. Canvax Description and Business Overview
 Table 182. Canvax Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 183. Canvax Clinical IVD Reagents Product
 Table 184. Canvax Recent Developments/Updates
 Table 185. Prestige Diagnostics Company Information
 Table 186. Prestige Diagnostics Description and Business Overview
 Table 187. Prestige Diagnostics Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 188. Prestige Diagnostics Clinical IVD Reagents Product
 Table 189. Prestige Diagnostics Recent Developments/Updates
 Table 190. Adaltis Company Information
 Table 191. Adaltis Description and Business Overview
 Table 192. Adaltis Clinical IVD Reagents Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 193. Adaltis Clinical IVD Reagents Product
 Table 194. Adaltis Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Clinical IVD Reagents Distributors List
 Table 198. Clinical IVD Reagents Customers List
 Table 199. Clinical IVD Reagents Market Trends
 Table 200. Clinical IVD Reagents Market Drivers
 Table 201. Clinical IVD Reagents Market Challenges
 Table 202. Clinical IVD Reagents Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Clinical IVD Reagents
 Figure 2. Global Clinical IVD Reagents Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Clinical IVD Reagents Market Share by Type: 2025 & 2032
 Figure 4. Antibodies Product Picture
 Figure 5. Antigens, Purified Proteins and Peptides Product Picture
 Figure 6. Olignucleotides Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Clinical IVD Reagents Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Clinical IVD Reagents Market Share by Application: 2025 & 2032
 Figure 10. Infectious Diseases
 Figure 11. Oncology Applications
 Figure 12. Endocrinology
 Figure 13. Blood Sreening
 Figure 14. Others
 Figure 15. Global Clinical IVD Reagents Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Clinical IVD Reagents Market Size (US$ Million), 2021–2032
 Figure 17. Global Clinical IVD Reagents Sales (Units), 2021–2032
 Figure 18. Global Clinical IVD Reagents Average Price (US$/Unit), 2021–2032
 Figure 19. Clinical IVD Reagents Report Years Considered
 Figure 20. Clinical IVD Reagents Sales Share by Manufacturers in 2025
 Figure 21. Global Clinical IVD Reagents Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global Clinical IVD Reagents Players: Market Share by Revenue in Clinical IVD Reagents in 2025
 Figure 23. Clinical IVD Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global Clinical IVD Reagents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America Clinical IVD Reagents Sales Market Share by Country (2021–2032)
 Figure 26. North America Clinical IVD Reagents Revenue Market Share by Country (2021–2032)
 Figure 27. United States Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe Clinical IVD Reagents Sales Market Share by Country (2021–2032)
 Figure 30. Europe Clinical IVD Reagents Revenue Market Share by Country (2021–2032)
 Figure 31. Germany Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific Clinical IVD Reagents Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific Clinical IVD Reagents Revenue Market Share by Region (2021–2032)
 Figure 38. China Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. China Taiwan Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Southeast Asia Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Clinical IVD Reagents Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Clinical IVD Reagents Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Colombia Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Clinical IVD Reagents Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Clinical IVD Reagents Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Clinical IVD Reagents Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Clinical IVD Reagents by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Clinical IVD Reagents by Type (2021–2032)
 Figure 58. Global Clinical IVD Reagents Price (US$/Unit) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Clinical IVD Reagents by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Clinical IVD Reagents by Application (2021–2032)
 Figure 61. Global Clinical IVD Reagents Price (US$/Unit) by Application (2021–2032)
 Figure 62. Clinical IVD Reagents Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS